Skip to main content
. 2022 Oct 21;12:999002. doi: 10.3389/fonc.2022.999002

Table 4.

Comparison of safety and efficiency-related outcomes between the two groups.

  Non-reinforcement group (n=64) Reinforcement group (n=64) P value§
Surgical approach 0.510
Open 4 (6.2) 6 (9.4)
Laparoscopic or robotic 60 (93.8) 58 (90.6)
Conversion to open surgery 4 (6.3) 4 (6.3) 1.000
Parenchyma firmness 0.466
Soft 56 (87.5) 52 (81.3)
Hard 8 (12.5) 12 (18.7)
Operative time (min) * 200 (100-460) 200 (110-440) 0.834#
Spleen preservation 12 (18.8) 12 (18.8) 1
Concomitant PV/SMV wall resection 8 (12.5) 8 (12.5) 1
Estimated blood loss (ml) * 100 (20-1000) 125 (20-1000) 0.712#
Transfusion 6 (9.4) 8 (12.5) 0.571
Duration of drainage (days) * 10 (6-60) 8 (3-60) 0.066#
Postoperative LOS (days) * 9 (6-25) 10 (6-26) 0.378#
Clavien-Dindo classification 0.528
Grade I or II 46 (71.9) 28 (43.8)
Grade IIIa 2 (3.1) 0 (0)
Grade IIIb 0 (0) 0 (0)
Grade IV or V 0 (0) 0 (0)
90-day mortality 0 (0) 0 (0) 1

Values in parentheses are percentages unless indicated otherwise; *values are median (range). PV, portal vein. SMV, superior mesentery vein. LOS, length of stay. † Including one delayed gastric emptying and one peri-pancreatic fluid accumulation with fever needing reintervention. § χ2 test, except ¶ Fisher’s exact test and # Mann–Whitney U test.